GEODE CAPITAL MANAGEMENT, LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$70
-100.0%
412,218
-5.4%
0.00%
Q3 2022$188,000
-49.2%
435,6460.0%0.00%
Q2 2022$370,000
-91.3%
435,646
-43.5%
0.00%
-100.0%
Q1 2022$4,246,000
-43.1%
770,636
+0.0%
0.00%0.0%
Q4 2021$7,457,000
-47.8%
770,370
-3.6%
0.00%
-50.0%
Q3 2021$14,295,000
-28.0%
799,508
-1.7%
0.00%
-33.3%
Q2 2021$19,852,000
+4.3%
813,297
+13.2%
0.00%0.0%
Q1 2021$19,041,000
+329.5%
718,553
+23.0%
0.00%
+200.0%
Q4 2020$4,433,000
+45.9%
584,132
-3.7%
0.00%0.0%
Q3 2020$3,039,000
-14.3%
606,615
+2.2%
0.00%0.0%
Q2 2020$3,547,000
+44.7%
593,283
+7.6%
0.00%0.0%
Q1 2020$2,452,000
-74.8%
551,161
-46.3%
0.00%0.0%
Q4 2019$9,744,000
+152.4%
1,025,740
+108.5%
0.00%0.0%
Q3 2019$3,861,000
-26.9%
491,870
+46.5%
0.00%0.0%
Q2 2019$5,279,000
-4.2%
335,640
+10.2%
0.00%0.0%
Q1 2019$5,513,000
-13.6%
304,624
-23.3%
0.00%0.0%
Q4 2018$6,384,000
+64.4%
397,074
+145.3%
0.00%0.0%
Q3 2018$3,884,000161,8450.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders